Skip to content Skip to footer
Subscribe Now
Viewpoints_Patrick Mooney
VIEWPOINTS
Patrick Mooney, CEO at SpyGlass Pharma, Shares Insights from the 3-Month Data of its Innovative Drug Delivery Platform for Chronic Eye Conditions
Shots:Patrick spoke about the 3-month data from the First-in-Human glaucoma treatment trial of Spyglass’ innovative  drug delivery platform that helps in lowering intraocular pressure in patients with glaucoma or ocular hypertensionPatrick also talked about the study design and key findings from the First-in-Human glaucoma treatment trialThe interview gives an understanding of Spyglass’…
November 29, 20220Comments
Viewpoints_Tim Clackson
VIEWPOINTS
Tim Clackson, President & CEO of Theseus Pharmaceuticals, Shares Insights on its Pan-Variant Inhibitor Therapies to Treat Cancer
Shots:Tim spoke about the development of THE-349, a fourth-generation small molecule for the treatment of EGFR-mutant NSCLCTim also talked about Thesus’ other small molecule, THE-630 in gastrointestinal stromal tumors (GIST) being evaluated in a P-I/II dose-escalation and expansion study The interview gives an understanding of how Thesus is developing different treatment options to…
November 28, 20220Comments
Viewpoints_Herson Quiñones
VIEWPOINTS
Herson Quiñones, VP at GSK Shares Insights on the FDA Approval of Benlysta for Pediatric Patients with Active Lupus Nephritis
Shots:Herson spoke about the approval of Benlysta by the US FDA for the treatment of children aged 5 to 17 with active lupus nephritis (LN) which often causes increased complications, hospitalizations, and mortality rates in childrenHe also talked about the etiology & epidemiology of lupus nephritis and how this disease is affecting millions…
November 22, 20220Comments
Viewpoints_Dr. Navdeep Tangri_Helen Yeh
VIEWPOINTS
Dr. Navdeep Tangri & Helen Yeh Shares Insights from the Data Presented at ASN Kidney Week 2022 on the Importance of Earlier Screening & Diagnosis of Chronic Kidney Disease
Shots:Dr. Navdeep spoke about the data presented at the ASN Kidney Week 2022 emphasizing on the urgent need for early screening of chronic kidney diseaseHelen Yeh talked about the treatment of CKD with Farxiga. She also focused on the patient support programs by AstraZeneca for the early diagnosis and screening of patientsThe…
November 21, 20220Comments
Disease of the Month: Epilepsy
INSIGHTS+
Disease of the Month: Epilepsy
INTRODUCTIONAlso known as seizure disorder, epilepsy is a non-communicable chronic disorder of the brain and is the fourth most common neurological disease globally. It is a central nervous system (CNS) disorder characterized by recurrent episodes of seizures that are short changes in normal brain activity which led to brief incidences of involuntary movements either…
November 16, 20220Comments